Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Behre

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Human Reproduction (Oxford, England)|September 2, 1999
Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDY1) genes from father to son through intracytoplasmic sperm injection: case reportA Kamischke, J Gromoll, M Simoni, et al.
Human Reproduction (Oxford, England)|February 10, 1998
Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignanciesS Kliesch, M Bergmann, L Hertle, et al.
European Journal of Endocrinology|May 7, 1999
Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studiesH M Behre, K Abshagen, M Oettel, et al.
Human Reproduction (Oxford, England)|October 21, 1999
DNA flow cytometry of human semenU B Hacker-Klom, W Göhde, E Nieschlag, et al.
Urological Research|January 1, 1992
The gonadotropin-releasing hormone (GnRH) agonist-induced initial rise of bioactive LH and testosterone can be blunted in a dose-dependent manner by GnRH antagonist in the non-human primateO P Sharma, G F Weinbauer, H M Behre, et al.
Journal of Reproduction and Fertility|January 1, 1994
Duration of the cycle of the seminiferous epithelium, estimated by the 5-bromodeoxyuridine technique, in laboratory and feral ratsG Rosiepen, G F Weinbauer, S Schlatt, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Long-term effect of testosterone therapy on bone mineral density in hypogonadal menH M Behre, S Kliesch, E Leifke, et al.
Fertility and Sterility|April 21, 1998
Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilizationC Rolf, H M Behre, T G Cooper, et al.
Human Reproduction (Oxford, England)|December 1, 2001
Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen aloneH M Behre, S Kliesch, B Lemcke, et al.
Clinical Endocrinology|November 1, 1990
Bio and immuno-activity of FSH in serum after intramuscular injection of highly purified urinary human FSH in normal menF Jockenhövel, U Fingscheidt, S A Khan, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Human Reproduction (Oxford, England)|September 2, 1999
Transmission of a Y chromosomal deletion involving the deleted in azoospermia (DAZ) and chromodomain (CDY1) genes from father to son through intracytoplasmic sperm injection: case reportA Kamischke, J Gromoll, M Simoni, et al.
Human Reproduction (Oxford, England)|February 10, 1998
Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignanciesS Kliesch, M Bergmann, L Hertle, et al.
European Journal of Endocrinology|May 7, 1999
Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studiesH M Behre, K Abshagen, M Oettel, et al.
Human Reproduction (Oxford, England)|October 21, 1999
DNA flow cytometry of human semenU B Hacker-Klom, W Göhde, E Nieschlag, et al.
Urological Research|January 1, 1992
The gonadotropin-releasing hormone (GnRH) agonist-induced initial rise of bioactive LH and testosterone can be blunted in a dose-dependent manner by GnRH antagonist in the non-human primateO P Sharma, G F Weinbauer, H M Behre, et al.
Journal of Reproduction and Fertility|January 1, 1994
Duration of the cycle of the seminiferous epithelium, estimated by the 5-bromodeoxyuridine technique, in laboratory and feral ratsG Rosiepen, G F Weinbauer, S Schlatt, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Long-term effect of testosterone therapy on bone mineral density in hypogonadal menH M Behre, S Kliesch, E Leifke, et al.
Fertility and Sterility|April 21, 1998
Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilizationC Rolf, H M Behre, T G Cooper, et al.
Human Reproduction (Oxford, England)|December 1, 2001
Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen aloneH M Behre, S Kliesch, B Lemcke, et al.
Clinical Endocrinology|November 1, 1990
Bio and immuno-activity of FSH in serum after intramuscular injection of highly purified urinary human FSH in normal menF Jockenhövel, U Fingscheidt, S A Khan, et al.
Pageof 12